Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.
Schmidt
Peter W
PW
Hirschl
Michael M
MM
Trautinger
Franz
F
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000328:Adult; D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001920:Bradykinin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D065094:Bradykinin B2 Receptor Antagonists; D006801:Humans; D008297:Male
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D065094:Bradykinin B2 Receptor Antagonists; C065679:icatibant; D001920:Bradykinin